# Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients

> **NCT07532356** · — · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Genomics
- Thyroid Cancer
- NGS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07532356
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2030-07-31
- **Final completion:** 2031-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07532356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07532356, "Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07532356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*